Location History:
- Rio Rancho, NM (US) (2021)
- Fort Collins, CO (US) (2018 - 2023)
Company Filing History:
4 out of 818 
1 out of 310 Years Active: 2018-2023
Title: Innovations in Lung Cancer Detection: The Contributions of Jennifer E Beane-Ebel
Introduction
Jennifer E Beane-Ebel is a prominent inventor based in Fort Collins, Colorado, known for her significant contributions to the field of lung cancer research. With a total of four patents to her name, she has developed innovative methods that enhance the diagnosis and treatment of bronchial premalignant lesions. Her work is pivotal in the early detection of lung cancer, which can lead to more effective interventions.
Latest Patents
Among her latest patents, one focuses on methods related to bronchial premalignant lesion severity and progression. This technology is directed towards treating and diagnosing bronchial premalignant lesions by determining the lesion subtype using specific biomarkers. Another notable patent involves a gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions. This patent discloses assays and methods for identifying premalignant lesions and assessing their likelihood of progression to lung cancer. The methods provide minimally invasive means of accurately detecting and monitoring the presence of these lesions, offering novel insights into the earliest stages of lung cancer.
Career Highlights
Jennifer has worked with esteemed institutions such as Boston University and Health Research, Inc. Her research has significantly advanced the understanding of lung cancer and its precursors, contributing to the development of innovative diagnostic tools.
Collaborations
Jennifer has collaborated with notable colleagues in her field, including Avrum Spira and Marc Elliott Lenburg. Their joint efforts have furthered research in lung cancer detection and treatment.
Conclusion
Jennifer E Beane-Ebel's work exemplifies the impact of innovation in medical research, particularly in the early detection of lung cancer. Her patents and collaborations highlight her commitment to improving patient outcomes through advanced diagnostic methods.